Umbuzo ovamile esivame ukubuza uma othile ethola ukuthi unesifo somdlavuza wesigaba samangqamuzana esingekho emincane, "Ngumuphi umgomo wokuphila komdlavuza wamaphaphu wamaphasethi?" Lokhu akulindelekile, kunikezwa isilinganiso esiphezulu sokusinda komdlavuza wamaphaphu. Ngaphambi kokuba uphendule lo mbuzo, kubalulekile ukuthi ukhulume kancane ngokuthi impendulo-impendulo yezibalo-itholakala kanjani.
Futhi, qiniseka ukuthi ufunda phansi kwalesi sihloko. Ukuphila komdlavuza we-Lung kuyathuthuka.
Izinhlobonhlobo ezithinta isiteleka sesi-2 se-Cancer Prognosis
Isikhathi sokuphila komdlavuza we-Stage 2 wamaphaphu singaphahluka kakhulu phakathi kwabantu abahlukene. Izibalo zisitshela ngabantu "abavamile", kodwa akekho ophakathi. Ezinye zalezi zinguquko zihlanganisa:
- Uhlobo lwakho lomdlavuza wamaphaphu nendawo - Umgudu wesibili wesifo somdlavuza uhlanganisa izinhlobo eziningana zomdlavuza wamaphaphu futhi uhlanganisa amacansana amancane kodwa asakaze kumalini amancane eseduze , kodwa angakaze asakaze kunoma iyiphi i-lymph nodes.
- Abantu bakho - Abantu abancane bavame ukuhlala isikhathi eside kunabantu asebekhulile abanomdlavuza wamaphaphu.
- Ubulili bakho - Isikhathi sokuphila sabesifazane abanomdlavuza wamaphaphu sikhulu esigabeni ngasinye somdlavuza wamaphaphu.
- Impilo yakho ejwayelekile ngesikhathi sokuxilongwa - Ukuphila ngokugcwele ngesikhathi sokuxilongwa kuhlotshaniswa nokuphila isikhathi eside, kanye nekhono elikhulu lokulwa nemithi yokwelapha engase isandise ukusinda.
- Indlela osabela ngayo ekwelapheni - Imiphumela emibi yokwelashwa njengokuhlinzwa, i- chemotherapy , ukwelashwa okuhlosiwe , kanye nokwelapha imishanguzo kuhlukahluka kubantu abahlukene futhi kunganciphisa ikhono lakho lokubekezelela ukwelashwa.
- Ezinye izimo zempilo ongase ube nazo - Izimo zezempilo ezifana nesifo se-emphysema noma isifo senhliziyo singanciphisa isigaba sesi-2 somdlavuza wempilo yomdlavuza wamaphaphu.
- Izinkinga zomdlavuza wamaphaphu - Izinkinga ezinjengezindwangu zegazi zinganciphisa ukusinda .
- Ukubhema - Ukuqhubeka ukubhema ngemuva kokuxilongwa kwesigaba 2 umdlavuza wamaphaphu kubonakala sengathi kuphila kancane. Siyanqikaza ukuletha ukubhema njengoba umgomo wethu ukukhipha umhlaba wehlazo lomdlavuza wamaphaphu (futhi ngenxa yokuthi kukhona abantu abangaboni kakhulu ababhemayo abatholakala benesifo) kodwa uma ubhema, kubalulekile ukuyeka. Hlola lezi zizathu eziyishumi zokuyeka ukubhema ngemuva kokuxilongwa komdlavuza .
Isigaba 2 Izibalo Zokusinda Ngomdlavuza Wegciwane Lomshukela kanye neCaveat
Isilinganiso sokusinda esiphezulu, okungukuthi amaphesenti abantu abalindeleke ukuba baphile eminyakeni emihlanu emva kokuxilongwa kwesigaba 2 somdlavuza wamaphaphu cishe cishe ngamaphesenti angu-30. Kubantu abanezinambuzane ezinkulu ezingakafiki kunoma yiliphi i-lymph nodes, izinga lokusinda lingase libe liphakeme kakhulu.
Sibelana ngezibalo mayelana nokuphila komdlavuza wamaphaphu ngoba abantu abaningi babuza lo mbuzo, kodwa kunezinto eziningana okudingeka uzigcine engqondweni. Izibalo ziyizinombolo ezitholakala ngokubheka ngemuva kwesikhathi ukubona ukuthi abantu benza kanjani uhlobo oluthile lomdlavuza. Ngamanye amazwi, ngokuvamile baneminyaka eminingana ubudala. Uma kucatshangwa ukuthi ukwelashwa okusha kuye kwasungulwa kusukela lezo zinombolo zabhalwa, amazinga okusinda awasitsheli lutho ngokuthi umuntu uzokwenzela kanjani izinhlinzeko ezintsha ezitholayo.
Ukuze kugcizelele ukuthi kubaluleke kangakanani lokhu, cabanga ukuthi kunezindlela ezintsha zokwelapha ezivunyelwe ukwelashwa komdlavuza wamaphaphu esikhathini esiphakathi kuka-2011 no-2015 kunalokho obekuvunyelwe eminyakeni engama-40 ngaphambi kuka-2015.
Ngaphandle kwalezi zindlela ezintsha zokwelapha, kunezinye izindlela eziningi zokwelashwa ezihlolwe ekuvivinyweni kwemitholampilo , futhi lezi zilingo zomtholampilo zinika abantu abathile ithuba lokuhlala bephila ukuthi bebengenayo ngisho eyodwa noma emibili edlule. Sivame ukuzwa kubantu abaye bahlanganyela emaqenjini okusekela umdlavuza wamaphaphu nasemiphakathini futhi babe ngummeli wabo ekunakekelweni komdlavuza wabo, bathole ukuvivinywa kokwelashwa ngisho nalapho umphakathi wabo oncologists bengakaqapheli.
Phela, ngubani okhuthazwa kakhulu ukucwaninga isifo sabo kunomuntu ohlala nalo nsuku zonke?
Ukusinda Kwemdlavuza Yengculaza Kuyathuthukisa
Kubalulekile ukuqaphela ukuthi ukusinda komdlavuza wamaphaphu, emva kokushintsha kancane eminyakeni eminingi, kuthuthuka. Akuyona nje imithi ephuthumayo.
Uma uthola ukuthi unomdlavuza wamaphaphu, qiniseka ukuthi ukhuluma nodokotela wakho mayelana nokuprofetha kwamangqamuzana (ukuhlolwa kofuzo) kwesisu sakho . Imithi ehloswe kubantu abane- EGFR , izinguquko ze- ROS1 , nokulungiswa kabusha kwe-ALK kuye kwashintsha ubuso bomdlavuza wamaphaphu. I-Immunotherapy nayo yenza umehluko ngemithi emibili emisha evunyiwe ngo-2015, ngisho nangabantu abane-cancer ephakeme. Yiba ngummeli wakho. Funda ngesifo sakho. Yibani ingxenye yomphakathi womdlavuza wamaphaphu online. Futhi, hlola lezi zincomo ekuthuthukiseni ukusinda komdlavuza wamapayipi ukuthi udokotela wakho angeke akhulume.
Imithombo:
I-American Cancer Society. Amanani nezinombolo ze-Cancer 2014 . I-Atlanta: I-American Cancer Society; 2014. http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf.
I-American Cancer Society. I-Cancer Lung (I-Cell Non-Small.) I-Non-Small Cell Lung Cancer Ukusinda Amanani nge Stage. http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-sall-cell-lung-cancer-survival-rates.
I-National Cancer Institute. Ukunakekelwa Kwemdlavuza Yamangqamuzana Angewona Amancane (PDQ) - I-Health Professional Version. https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq#section/all
Parsons, A. et al. Umthelela Wokuqeda Ukubhema Emva kokuthola Ukuhlolwa Kwegciwane Lokuqala Lomgogodla Nge-Prognosis: Ukubuyekezwa Okuhlelekile Kwezingqinamba Zokuqapha Nge-Meta-Analysis. I-British Medical Journal BMJ2010; 340: b5569. Ishicilelwe ku-intanethi 21 Januwari 2010.
Wisnivesky, J. et al. Ukuchazwa kwesifo se-Stage II esingeyona-encane yesifo somdlavuza ngokusho kwesimo sokugcoba nesimo se-Nodal ekuboneni. I-Cancer Lung . 2005. 49 (2): 181-186.